The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells
How the REGγ-proteasome pathway is regulated during the cell cycle or genotoxic insults remains unclear. Here, the authors show that NIP30 acts as a molecular switch to regulate the REGγ-proteasome activity and may provide an approach to combat drug-resistant tumours lacking functional p53.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7b5a15238e124a499bbec73fb760c725 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7b5a15238e124a499bbec73fb760c725 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7b5a15238e124a499bbec73fb760c7252021-12-02T14:53:44ZThe REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells10.1038/s41467-020-17667-72041-1723https://doaj.org/article/7b5a15238e124a499bbec73fb760c7252020-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-17667-7https://doaj.org/toc/2041-1723How the REGγ-proteasome pathway is regulated during the cell cycle or genotoxic insults remains unclear. Here, the authors show that NIP30 acts as a molecular switch to regulate the REGγ-proteasome activity and may provide an approach to combat drug-resistant tumours lacking functional p53.Xiao GaoQingwei WangYing WangJiang LiuShuang LiuJian LiuXingli ZhouLi ZhouHui ChenLinian PanJiwei ChenDa WangQing ZhangShihui ShenYu XiaoZhipeng WuYiyun ChengGeng ChenSyeda KubraJun QinLan HuangPei ZhangChuangui WangRobb E. MosesDavid M. LonardBert W. O’ MalleyFuad FaresBianhong ZhangXiaotao LiLei LiJianru XiaoNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-10 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Xiao Gao Qingwei Wang Ying Wang Jiang Liu Shuang Liu Jian Liu Xingli Zhou Li Zhou Hui Chen Linian Pan Jiwei Chen Da Wang Qing Zhang Shihui Shen Yu Xiao Zhipeng Wu Yiyun Cheng Geng Chen Syeda Kubra Jun Qin Lan Huang Pei Zhang Chuangui Wang Robb E. Moses David M. Lonard Bert W. O’ Malley Fuad Fares Bianhong Zhang Xiaotao Li Lei Li Jianru Xiao The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells |
description |
How the REGγ-proteasome pathway is regulated during the cell cycle or genotoxic insults remains unclear. Here, the authors show that NIP30 acts as a molecular switch to regulate the REGγ-proteasome activity and may provide an approach to combat drug-resistant tumours lacking functional p53. |
format |
article |
author |
Xiao Gao Qingwei Wang Ying Wang Jiang Liu Shuang Liu Jian Liu Xingli Zhou Li Zhou Hui Chen Linian Pan Jiwei Chen Da Wang Qing Zhang Shihui Shen Yu Xiao Zhipeng Wu Yiyun Cheng Geng Chen Syeda Kubra Jun Qin Lan Huang Pei Zhang Chuangui Wang Robb E. Moses David M. Lonard Bert W. O’ Malley Fuad Fares Bianhong Zhang Xiaotao Li Lei Li Jianru Xiao |
author_facet |
Xiao Gao Qingwei Wang Ying Wang Jiang Liu Shuang Liu Jian Liu Xingli Zhou Li Zhou Hui Chen Linian Pan Jiwei Chen Da Wang Qing Zhang Shihui Shen Yu Xiao Zhipeng Wu Yiyun Cheng Geng Chen Syeda Kubra Jun Qin Lan Huang Pei Zhang Chuangui Wang Robb E. Moses David M. Lonard Bert W. O’ Malley Fuad Fares Bianhong Zhang Xiaotao Li Lei Li Jianru Xiao |
author_sort |
Xiao Gao |
title |
The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells |
title_short |
The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells |
title_full |
The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells |
title_fullStr |
The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells |
title_full_unstemmed |
The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells |
title_sort |
regγ inhibitor nip30 increases sensitivity to chemotherapy in p53-deficient tumor cells |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/7b5a15238e124a499bbec73fb760c725 |
work_keys_str_mv |
AT xiaogao theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT qingweiwang theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT yingwang theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT jiangliu theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT shuangliu theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT jianliu theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT xinglizhou theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT lizhou theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT huichen theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT linianpan theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT jiweichen theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT dawang theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT qingzhang theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT shihuishen theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT yuxiao theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT zhipengwu theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT yiyuncheng theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT gengchen theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT syedakubra theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT junqin theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT lanhuang theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT peizhang theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT chuanguiwang theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT robbemoses theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT davidmlonard theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT bertwomalley theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT fuadfares theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT bianhongzhang theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT xiaotaoli theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT leili theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT jianruxiao theregginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT xiaogao regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT qingweiwang regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT yingwang regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT jiangliu regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT shuangliu regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT jianliu regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT xinglizhou regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT lizhou regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT huichen regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT linianpan regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT jiweichen regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT dawang regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT qingzhang regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT shihuishen regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT yuxiao regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT zhipengwu regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT yiyuncheng regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT gengchen regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT syedakubra regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT junqin regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT lanhuang regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT peizhang regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT chuanguiwang regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT robbemoses regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT davidmlonard regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT bertwomalley regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT fuadfares regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT bianhongzhang regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT xiaotaoli regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT leili regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells AT jianruxiao regginhibitornip30increasessensitivitytochemotherapyinp53deficienttumorcells |
_version_ |
1718389392661282816 |